Issuance of Stock Acquisition Rights for Directors and Employees
First written in FY2017-Q2. 1 of 6 entries say "Restated". Latest entry: FY2023.
- FY2023Exercise of 80,000 shares under 2013 stock optionsAnnual report
「2013 stock options① (8th Series A stock acquisition rights): vested 80,000; exercised 80,000; unexercised balance: —」
Under the 2013 Series A stock options, 80,000 shares vested and were exercised, leaving no unexercised balance. - FY2022Vesting, exercise and lapse of 2016 stock optionsAnnual report
「2016 stock options: vested 421,600; exercised 374,800; lapsed 46,800; unexercised balance: —」
Under the 2016 stock options, 421,600 shares vested, 374,800 shares were exercised and 46,800 shares lapsed, leaving no unexercised balance. - FY2019Lapse of rightsAnnual report
「The decrease in the 2013 stock acquisition rights②, 2015 stock acquisition rights② and 2016 stock acquisition rights was due to the lapse of the rights.」
The Company states that multiple rights under existing stock acquisition rights lapsed. - FY2018-Q2AdvancedAnnual report
「The stock acquisition rights issued during the second quarter accounting period were as follows.」
The Company issued stock acquisition rights covering a total of 300,000 shares under the 11th and 12th series of stock acquisition rights. The exercise period is from 1 July 2023 to 31 March 2024, subject to conditions including consolidated ordinary profit of at least ¥2.5 billion for the fiscal year ended June 2022. - FY2017RestatedAnnual report
「2016 stock options: categories and numbers of eligible grantees: 87 employees of the Company; 17 employees of the Company's subsidiaries; number of stock options: common shares, 358,200 shares」
The annual report confirms the eligible grantees and details of the 358,200 shares underlying the stock acquisition rights granted to directors, officers, employees and others. - FY2017-Q2First statedAnnual report
「The stock acquisition rights issued during the second quarter accounting period were as follows: Number of stock acquisition rights (rights): 3,582; number of shares underlying the stock acquisition rights (shares): 358,200; exercise period: 1 October 2021 to 31 March 2022.」
The Company issued 3,582 stock acquisition rights to directors, officers and employees, covering 358,200 underlying shares, with an exercise period from 1 October 2021 to 31 March 2022.